Alector reported a Phase 2 failure for an AbbVie-partnered Alzheimer’s program Monday afternoon and said it will need to lay off staff.
Researchers were examining …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The FDA’s director of its Office of Medical Policy wants trial sponsors to keep participant experiences top-of-mind in their decentralized designs. Endpoints News sat down
When Shwen Gwee launched Vertex Pharmaceuticals on Twitter in 2010, he pitched it as a one-month experiment. No one at the then-precommercial biotech knew much